162 related articles for article (PubMed ID: 34910240)
1. PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.
Schwarz R; Zitzow E; Fiebig A; Hering S; Humboldt Y; Schoenwaelder N; Kämpfer N; Volkmar K; Hinz B; Kreikemeyer B; Maletzki C; Fiedler T
Appl Microbiol Biotechnol; 2022 Jan; 106(1):261-271. PubMed ID: 34910240
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells.
Riess C; Del Moral K; Fiebig A; Kaps P; Linke C; Hinz B; Rupprecht A; Frank M; Fiedler T; Koczan D; Troschke-Meurer S; Lode HN; Engel N; Freitag T; Classen CF; Maletzki C
Cell Death Dis; 2022 Jun; 13(6):555. PubMed ID: 35717443
[TBL] [Abstract][Full Text] [Related]
3. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
Fiedler T; Strauss M; Hering S; Redanz U; William D; Rosche Y; Classen CF; Kreikemeyer B; Linnebacher M; Maletzki C
Cancer Biol Ther; 2015; 16(7):1047-55. PubMed ID: 25774632
[TBL] [Abstract][Full Text] [Related]
4. The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C.
Linke C; Freitag T; Riess C; Scheffler JV; Del Moral K; Schoenwaelder N; Fiedler T; Fiebig A; Kaps P; Dubinski D; Schneider B; Bergmann W; Classen CF; Maletzki C
Cancer Cell Int; 2023 Feb; 23(1):38. PubMed ID: 36843002
[TBL] [Abstract][Full Text] [Related]
5. Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas.
Maletzki C; Rosche Y; Riess C; Scholz A; William D; Classen CF; Kreikemeyer B; Linnebacher M; Fiedler T
Chem Biol Interact; 2017 Dec; 278():179-188. PubMed ID: 28989041
[TBL] [Abstract][Full Text] [Related]
6. PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida.
Zhang L; Liu M; Jamil S; Han R; Xu G; Ni Y
Cancer Lett; 2015 Feb; 357(1):346-354. PubMed ID: 25462857
[TBL] [Abstract][Full Text] [Related]
7. Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer.
Chung SF; Kim CF; Kwok SY; Tam SY; Chen YW; Chong HC; Leung SL; So PK; Wong KY; Leung YC; Lo WH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545874
[TBL] [Abstract][Full Text] [Related]
8. Rational surface engineering of an arginine deiminase (an antitumor enzyme) for increased PEGylation efficiency.
Cheng F; Yang J; Schwaneberg U; Zhu L
Biotechnol Bioeng; 2019 Sep; 116(9):2156-2166. PubMed ID: 31062871
[TBL] [Abstract][Full Text] [Related]
9. Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.
Singh PK; Deorukhkar AA; Venkatesulu BP; Li X; Tailor R; Bomalaski JS; Krishnan S
Mol Cancer Ther; 2019 Dec; 18(12):2381-2393. PubMed ID: 31395686
[TBL] [Abstract][Full Text] [Related]
10. Amino Acid Uptake Measured by [
Prudner BC; Sun F; Kremer JC; Xu J; Huang C; Sai KKS; Morgan Z; Leeds H; McConathy J; Van Tine BA
Theranostics; 2018; 8(8):2107-2116. PubMed ID: 29721066
[No Abstract] [Full Text] [Related]
11. Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Curley SA; Bomalaski JS; Ensor CM; Holtsberg FW; Clark MA
Hepatogastroenterology; 2003; 50(53):1214-6. PubMed ID: 14571701
[TBL] [Abstract][Full Text] [Related]
12. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
[TBL] [Abstract][Full Text] [Related]
13. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.
Kim RH; Coates JM; Bowles TL; McNerney GP; Sutcliffe J; Jung JU; Gandour-Edwards R; Chuang FY; Bold RJ; Kung HJ
Cancer Res; 2009 Jan; 69(2):700-8. PubMed ID: 19147587
[TBL] [Abstract][Full Text] [Related]
14. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
[TBL] [Abstract][Full Text] [Related]
15. Role of arginine deiminase in thymic atrophy during experimental Streptococcus pyogenes infection.
Starikova EA; Golovin AS; Vasilyev KA; Karaseva AB; Serebriakova MK; Sokolov AV; Kudryavtsev IV; Burova LA; Voynova IV; Suvorov AN; Vasilyev VB; Freidlin IS
Scand J Immunol; 2019 Feb; 89(2):e12734. PubMed ID: 30471128
[TBL] [Abstract][Full Text] [Related]
16. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
17. Pegylated arginine deiminase depletes plasma arginine but maintains tissue arginine availability in young pigs.
Mohammad MA; Didelija IC; Stoll B; Nguyen TC; Marini JC
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E641-E652. PubMed ID: 33427052
[TBL] [Abstract][Full Text] [Related]
18. Kinetic characterization of arginine deiminase and carbamate kinase from Streptococcus pyogenes M49.
Hering S; Sieg A; Kreikemeyer B; Fiedler T
Protein Expr Purif; 2013 Sep; 91(1):61-8. PubMed ID: 23867361
[TBL] [Abstract][Full Text] [Related]
19. Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition.
Qi H; Wang Y; Yuan X; Li P; Yang L
Nanoscale; 2020 Dec; 12(47):24030-24043. PubMed ID: 33291128
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity.
El-Sayed ASA; Shindia AA; Zeid AAA; Yassin AM; Sitohy MZ; Sitohy B
Enzyme Microb Technol; 2019 Dec; 131():109432. PubMed ID: 31615671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
